SCHEMBL17824873

SCHEMBL17824873

O=NS(=O)(=O)c1ccc2cnncc2c1

nearest known ligand 0.39

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.39
PRSS1 P07477 2/20 0.39
PRSS2 P07478 2/20 0.39
PRSS3 P35030 2/20 0.39
LMNA P02545 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10698904 0.76 ALDH1A1 (0.43) F2PRSS1PRSS2PRSS3LMNA
SCHEMBL14509008 0.76 ALDH1A1 (0.50) LMNAL3MBTL1
SCHEMBL28174372 0.76 LMNA (0.59) LMNA
SCHEMBL28850126 0.70 EGFR (0.49) F2PRSS1PRSS2PRSS3
SCHEMBL17824589 0.68 FYN (0.33)
SCHEMBL30375789 0.67 NAMPT (0.40)
SCHEMBL14629169 0.63 LMNA (0.71) LMNA
SCHEMBL17845255 0.62 PRKCI (0.49) L3MBTL1
SCHEMBL17787430 0.61 F2 (0.57) F2PRSS1PRSS2PRSS3
SCHEMBL663730 0.61 CYP2C19 (0.59) F2PRSS1PRSS2PRSS3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
CN-107207467-A 2, 4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARG 癌症研究科技有限公司 2017-09-26 CN disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed